K2M closes common stock sale — 5 key updates

Spinal Tech

K2M closed its sale of common stock on Feb. 12.

 

Here are five things to know about the sale:

 

1. K2M sold 906,748 shares of common stock in their follow-on offering pursuant to the underwriters' option to purchase additional shares.

 

2. The shares were purchased at $18.75 per share before underwriting discounts.

 

3. K2M didn't receive any proceeds from the sale.

 

4. Piper Jaffray & Co., Barclays Capital and Wells Fargo Securities are joint book-running managers for the offering.

 

5. William Blair & Company and Cowen and Company are co-managers.

 

There has also been a great deal of action for individuals selling stock over the past few days:

 

• John Philip Kostuik, MD, sold 83,807 shares in a $1.4 million transaction
• Director Ray A. Ranelli sold 14,000 shares in a $262,500 transaction
• Wcas Management sold 3,738 shares in a $70,087.50 transaction

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers